• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nutritional control of antibiotic production by Streptomyces platensis MA7327: importance of l-aspartic acid.天蓝色链霉菌MA7327抗生素生产的营养控制:L-天冬氨酸的重要性
J Antibiot (Tokyo). 2017 Jul;70(7):828-831. doi: 10.1038/ja.2017.49. Epub 2017 May 3.
2
Platensimycin and platencin congeners from Streptomyces platensis.来自链霉菌的棒曲霉素和棒曲霉素同系物。
J Nat Prod. 2011 Mar 25;74(3):329-40. doi: 10.1021/np100635f. Epub 2011 Jan 7.
3
Engineered Streptomyces platensis strains that overproduce antibiotics platensimycin and platencin.过量生产抗生素普拉特链霉菌素和普拉特菌素的工程化天蓝色链霉菌菌株。
Antimicrob Agents Chemother. 2009 Apr;53(4):1299-304. doi: 10.1128/AAC.01358-08. Epub 2009 Jan 21.
4
Development of a semi-defined medium supporting production of platensimycin and platencin by Streptomyces platensis.开发一种半确定培养基,用于支持变铅青链霉菌生产普拉地霉素和普拉菌素。
J Antibiot (Tokyo). 2013 Feb;66(2):51-4. doi: 10.1038/ja.2012.97. Epub 2012 Nov 28.
5
Isolation, enzyme-bound structure and antibacterial activity of platencin A1 from Streptomyces platensis.来自浅青紫链霉菌的普拉特烯素A1的分离、酶结合结构及抗菌活性
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4756-9. doi: 10.1016/j.bmcl.2009.06.061. Epub 2009 Jun 17.
6
Platensimycin and platencin: promising antibiotics for future application in human medicine.棒曲霉素和棒曲霉素:未来在人类医学中具有广阔应用前景的抗生素。
J Antibiot (Tokyo). 2011 Nov;64(11):705-10. doi: 10.1038/ja.2011.80. Epub 2011 Sep 14.
7
Engineering of Streptomyces platensis MA7339 for overproduction of platencin and congeners.工程菌 Streptomyces platensis MA7339 高产棒曲霉素及其同系物。
Org Lett. 2010 Apr 16;12(8):1744-7. doi: 10.1021/ol100342m.
8
Mechanisms of self-resistance in the platensimycin- and platencin-producing Streptomyces platensis MA7327 and MA7339 strains.产生扁枝衣霉素和扁枝菌素的天蓝色链霉菌MA7327和MA7339菌株中的自身抗性机制。
Chem Biol. 2014 Mar 20;21(3):389-397. doi: 10.1016/j.chembiol.2014.01.005. Epub 2014 Feb 20.
9
Titer improvement and pilot-scale production of platensimycin from Streptomyces platensis SB12026.来自浅蓝链霉菌SB12026的扁枝衣霉素的效价提高及中试规模生产
J Ind Microbiol Biotechnol. 2016 Jul;43(7):1027-35. doi: 10.1007/s10295-016-1769-z. Epub 2016 Apr 28.
10
Structure and semisynthesis of platensimide A, produced by Streptomyces platensis.由浅青紫链霉菌产生的普拉特西米德A的结构与半合成
Org Lett. 2008 May 1;10(9):1699-702. doi: 10.1021/ol800251v. Epub 2008 Apr 8.

引用本文的文献

1
Revealing Genome-Based Biosynthetic Potential of sp. BR123 Isolated from Sunflower Rhizosphere with Broad Spectrum Antimicrobial Activity.揭示从向日葵根际分离的具有广谱抗菌活性的sp. BR123基于基因组的生物合成潜力。
Antibiotics (Basel). 2022 Aug 4;11(8):1057. doi: 10.3390/antibiotics11081057.
2
Systematic optimization for production of the anti-MRSA antibiotics WAP-8294A in an engineered strain of Lysobacter enzymogenes.在工程化的 Lysobacter enzymogenes 菌株中生产抗耐甲氧西林金黄色葡萄球菌抗生素 WAP-8294A 的系统优化。
Microb Biotechnol. 2019 Nov;12(6):1430-1440. doi: 10.1111/1751-7915.13484. Epub 2019 Sep 14.
3
Bioprocessing strategies for cost-effective large-scale biogenic synthesis of nano-MgO from endophytic Streptomyces coelicolor strain E72 as an anti-multidrug-resistant pathogens agent.从内生链霉菌 E72 中生物有效大规模生物合成纳米氧化镁的生物加工策略,作为一种抗多药耐药性病原体的药物。
Sci Rep. 2018 Feb 28;8(1):3820. doi: 10.1038/s41598-018-22134-x.

本文引用的文献

1
Antibiotic resistance-the need for global solutions.抗生素耐药性——全球解决方案的必要性。
Lancet Infect Dis. 2013 Dec;13(12):1057-98. doi: 10.1016/S1473-3099(13)70318-9. Epub 2013 Nov 17.
2
The use of platensimycin and platencin to fight antibiotic resistance.使用扁枝衣霉素和扁枝衣菌素对抗抗生素耐药性。
Infect Drug Resist. 2013 Sep 18;6:99-114. doi: 10.2147/IDR.S25076.
3
Development of a chemically defined medium for the production of the antibiotic platensimycin by Streptomyces platensis.开发一种用于生产放线菌属盘基丝菌所产生的抗生素普拉地霉素的化学成分确定的培养基。
Appl Microbiol Biotechnol. 2013 Nov;97(21):9535-9. doi: 10.1007/s00253-013-5201-6.
4
Development of a semi-defined medium supporting production of platensimycin and platencin by Streptomyces platensis.开发一种半确定培养基,用于支持变铅青链霉菌生产普拉地霉素和普拉菌素。
J Antibiot (Tokyo). 2013 Feb;66(2):51-4. doi: 10.1038/ja.2012.97. Epub 2012 Nov 28.
5
Platensimycin and platencin: promising antibiotics for future application in human medicine.棒曲霉素和棒曲霉素:未来在人类医学中具有广阔应用前景的抗生素。
J Antibiot (Tokyo). 2011 Nov;64(11):705-10. doi: 10.1038/ja.2011.80. Epub 2011 Sep 14.
6
Dedicated ent-kaurene and ent-atiserene synthases for platensimycin and platencin biosynthesis.专用于platensimycin 和 platencin 生物合成的 ent-kaurene 和 ent-atiserene 合酶。
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13498-503. doi: 10.1073/pnas.1106919108. Epub 2011 Aug 8.
7
Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.选择性脂肪酸合酶(FAS)抑制剂platensimycin 在糖尿病小鼠模型中的抗糖尿病和抗脂肪变性作用。
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5378-83. doi: 10.1073/pnas.1002588108. Epub 2011 Mar 9.
8
Bioprospecting for antituberculosis leads from microbial metabolites.从微生物代谢产物中寻找抗结核先导化合物。
Nat Prod Rep. 2010 Nov;27(11):1709-19. doi: 10.1039/c0np00008f. Epub 2010 Oct 4.
9
New antibiotic structures from fermentations.从发酵产物中寻找新的抗生素结构。
Expert Opin Ther Pat. 2010 Oct;20(10):1359-71. doi: 10.1517/13543776.2010.509347.
10
Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthases.普拉他汀对分枝杆菌β-酮酰基-ACP合酶的活性。
PLoS One. 2009 Jul 17;4(7):e6306. doi: 10.1371/journal.pone.0006306.

天蓝色链霉菌MA7327抗生素生产的营养控制:L-天冬氨酸的重要性

Nutritional control of antibiotic production by Streptomyces platensis MA7327: importance of l-aspartic acid.

作者信息

Falzone Maria, Crespo Emmanuel, Jones Klarissa, Khan Gulaba, Korn Victoria L, Patel Amreen, Patel Mira, Patel Krishnaben, Perkins Carrie, Siddiqui Sana, Stenger Drew, Yu Eileen, Gelber Michael, Scheffler Robert, Nayda Vasyl, Ravin Ariela, Komal Ronica, Rudolf Jeffrey D, Shen Ben, Gullo Vincent, Demain Arnold L

机构信息

Research Institute of Scientists Emeriti (RISE), Charles A. Dana Research Institute, Drew University, Madison, NJ, USA.

Department of Chemistry, The Scripps Research Institute, Jupiter, FL, USA.

出版信息

J Antibiot (Tokyo). 2017 Jul;70(7):828-831. doi: 10.1038/ja.2017.49. Epub 2017 May 3.

DOI:10.1038/ja.2017.49
PMID:28465627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5642980/
Abstract

Streptomyces platensis MA7327 is a bacterium producing interesting antibiotics, which act by the novel mechanism of inhibiting fatty acid biosynthesis. The antibiotics produced by this actinomycete are platensimycin and platencin plus some minor related antibiotics. Platensimycin and platencin have activity against antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus; they also lack toxicity in animal models. Platensimycin also has activity against diabetes in a mouse model. We have been interested in studying the effects of primary metabolites on production of these antibiotics in our chemically defined production medium. In the present work, we tested 32 primary metabolites for their effect. They included 20 amino acids, 7 vitamins and 5 nucleic acid derivatives. Of these, only l-aspartic acid showed stimulation of antibiotic production. We conclude that the stimulatory effect of aspartic acid is due to its role as a precursor involved in the biosynthesis of aspartate-4-semialdehyde, which is the starting point for the biosynthesis of the 3-amino-2,4-dihydroxy benzoic acid portion of the platensimycin molecule.

摘要

普拉特链霉菌MA7327是一种能产生有趣抗生素的细菌,其作用机制是通过抑制脂肪酸生物合成这一新颖方式。这种放线菌产生的抗生素有扁平霉素和扁平菌素以及一些少量的相关抗生素。扁平霉素和扁平菌素对耐抗生素细菌如耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌有活性;它们在动物模型中也没有毒性。在小鼠模型中,扁平霉素对糖尿病也有活性。我们一直对在化学成分明确的生产培养基中研究初级代谢产物对这些抗生素产量的影响感兴趣。在目前的工作中,我们测试了32种初级代谢产物的作用。它们包括20种氨基酸、7种维生素和5种核酸衍生物。其中,只有L-天冬氨酸显示出对抗生素生产的刺激作用。我们得出结论,天冬氨酸的刺激作用是由于它作为参与天冬氨酸-4-半醛生物合成的前体的作用,而天冬氨酸-4-半醛是扁平霉素分子中3-氨基-2,4-二羟基苯甲酸部分生物合成的起点。